← Eichor
Study identifier: NCT06854198 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Glaucoma Screening to Enhance At-Risk Californians' Health

Condition: Glaucoma  ·  Sponsor: University of California, San Francisco

PhaseNA
Planned participants2000
Who can joinAll sexes, 50 Years to no upper limit
Healthy volunteersYes

About this study

The vast majority of glaucoma cases in the United States go undetected and untreated until the late stages of the disease. Open-angle glaucoma is a progressive condition that is asymptomatic in its early to moderate stages and may be amenable to screening through telemedicine-based approaches. This study is a randomized trial to evaluate whether glaucoma screening with established tests (e.g., optical coherence tomography, fundus photography, and tonometry) is more effective for detecting undiagnosed glaucoma cases compared to education alone or delayed intervention.

This description comes directly from the study's public registry record.

Talk to the study team

Atnasia Mekonnen, MS  ·  510-603-3330  ·  atnasia.mekonnen@ucsf.edu

Dionna Wittberg, MPH  ·  330-308-3016  ·  dionna.wittberg@ucsf.edu

Always discuss trial participation with your own doctor first.

Locations (2)

Baywell HealthOakland, California, United StatesRecruiting
University of California, San FranciscoSan Francisco, California, United StatesNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06854198